Startups
Iantrek, Inc.
Iantrek is a White Plains, New York ophthalmic medical-device company founded in2019 by ophthalmologist Sean Ianchulev. It develops micro-interventional and bio-interventional surgical technologies for glaucoma, a chronic disease that damages the optic nerve. Its published products include AlloFlo Uveo allogeneic scleral biotissue and the AlloSert Uveo delivery system for the uveoscleral outflow pathway, and C-Rex instrumentation for the trabecular pathway. The current pipeline also names Project Erie and C-Rex Duo at differing development stages. The company reports commercial availability of AlloFlo Uveo and AlloSert Uveo; product-specific instructions, clinical evidence and regulatory classifications must be assessed separately. FDA registration, human biotissue labeling and device clearance are not interchangeable approval claims. The profile does not establish a commercial artificial-intelligence product. Adam Szaronos became CEO inFebruary2025, succeeding founder Sean Ianchulev, who remains chairman and chief medical officer. The issuer announced a USD23M Series B onAugust30,2022 and USD42M Series C onAugust20,2025. A later Trinity Capital USD30M debt facility is a commitment, not proven company cash proceeds; the lender’s June2026 reported loan principal is a portfolio balance rather than verified original cash raised. Delaware incorporation in2019 is independently supported by the company’s SECFormD. This identity replaces an incorrect transportation-sector description and preserves the existing Iantrek financing graph.
Team
 Adam SzaronosChief Executive Officer and Board Member |
 Andrew CorleyBoard Observer |
 Casey TanseyBoard Member |
 David ChangClinical Adviser |
 Iqbal Ike AhmedMedical adviser — testimonial affiliation; CMO title unconfirmed |
 Jeffry WeinhuffBoard Member |
 Jim MazzoBoard Member |
 Marc-André MarcotteBoard Member |
 Robert N. WeinrebBoard Member |
 Sean IanchulevFounder, Chairman and Chief Medical Officer |
 Stephen BlochBoard Observer |
 Todd SoneBoard Member |